AKT1 and acute lymphoblastic leukemia: Our study found that CpG 685 can downregulate the levels of phosphorylated AKT and phosphorylated JNK1 in Sup-B15, which may provide combined treatment strategies against TKI resistance in Ph+ B-ALL.